Ozempic’s Unknowns
Nearly half of Americans say they’re willing to pay for weight-loss drugs. But what are the downsides to these so-called “miracle drugs”? Johann Hari is the author of the book, “Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight Loss Drugs.” Ricky Mulvey caught up with Hari for a…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Motley Fool Hidden Gems Investing
See all episodes →
Behind The Most Exciting Stock Pop In Years!
The Bond Market Selloff is Showing up in Earnings Reports
Berkshire Hathaway Hasn’t Done This in Over 3 Years
Similar episodes from other shows
More like Motley Fool Hidden Gems Investing →
Here's How the New Weight Loss Drugs Could Change Everything
Johann Hari: Uncovering if Ozempic is a Miracle Drug or Health Hazard & 3 Things They Do Not Want To Tell About Ozempic
Johann Hari: Uncovering if Ozempic is a Miracle Drug or Health Hazard & 3 Things They Do Not Want To Tell About Ozempic
Johann Hari: What They Don't Tell You About Ozempic
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.